Fidson Healthcare reported revenues of N4.4 billion in the second quarter of 2020 compared to N3.8 billion same period in 2020.
Key highlights – 2020 Q2
- Revenues surged to N4.69B +24.1% year YoY
- Revenues from Ethical Unit rose to N2.5 billion +37.9% YoY
- Revenues from over the counter drug sales rose to N1.94 billion -4.2% YoY
- Pre-tax profits more than doubled in the quarter to N512.7 million +166% YoY
Bottom Line: Fidson got a major boost from increase in its Ethical unit. The ethical division includes prescription drugs. Pharmaceutical companies have recorded a major boost in revenues in the last few months mostly due to COVID-19.
Follow our live results feeds
